Clinical Trial

Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

Name: Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation — clinical trial record (NCT07267949)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: END-AF-1

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-25.

Trial Details

NCT Number	NCT07267949
Lead Sponsor	Acesion Pharma
Conditions	Atrial Fibrillation (AF)
Enrollment	200 participants
Start Date	2025-10-22
Primary Completion	2026-11 (estimated)
Study Completion	2026-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-12